Skip to content

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL: multicenter alternative study

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL: multicenter alternative study - The development of nutrition therapy for latter-stage elderly to maintain and improve ADL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032813
Enrollment
400
Registered
2018-06-01
Start date
2018-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fracture, pneumonia, urinary tract infection, cancer

Interventions

Intensive nutrition (energy 25-35 kcal/kgBW, protein 1.5 g/kgBW, vitamin D 10 microg) Conventional nutrition (energy 25-35 kcal/kgBW, protein 1.0 g/kgBW)

Sponsors

Kansai Electric Power Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)75 years old at the first date of hospitalization (2) Patients with fracture, pneumonia, urinary tract infection, cancer (3) Nursing necessary degree of B is less than three points during hospitalization (4) MNA-Short Form is 8 to 11 points

Exclusion criteria

Exclusion criteria: (1) Dementia or mental disease (2) Using steroid (3) Severe liver and/or renal dysfunction (Child-Pugh classification > 7, Cre > 2 mg/dL) (4) Heart failure (New York Heart Association class 2, 3, 4) (5) Severe diabetic complications (nephropathy; stage 3-4, proliferative retinopathy, neuropathy) (6) Patients with SIRS or AIS score > 4 (7) Patients with the past of the gastrointestinal operation (8) Cancer which cannot cure radically (9) Patients with a pacemaker or the shrubbery model defibrillator (10) Patients who have motor paralysis in their limbs due to neuromuscular disease (11) Patient who judged that a study enforcement person in charge or a study partaker was unsuitable for this clinical study

Design outcomes

Primary

MeasureTime frame
Changes of the activity of daily living, skeletal muscle mass, muscle strength

Secondary

MeasureTime frame
Changes of dietary intakes (energy, protein, vitamin D, etc.), hemoglobin, aspartate aminotransferase, alanine aminotransferase, creatinine, blood urea nitrogen, estimated glomerular filtration rate, serum albumin, c-reactive protein.

Countries

Japan

Contacts

Public ContactNoboru Makabe

Kansai Electric Power Hospital The AMED Seino squad secretariat

n-makabe@umin.ac.jp06-6458-5821

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026